https://info.sinclairbioresources.com/background-data-in-the-sinclair-nanopig-sot-2024
The poster was presented at the 2024 SOT meeting and provides normal reference data for the Sinclair Nanopig, including body weight, hematology, clinical chemistry, ECG, and ophthalmology measures across age groups to support its use in preclinical drug development. It shows that the Nanopig’s physiological and clinical parameters are consistent with established miniature swine lineages and suitable for toxicology studies, while its smaller size (comparable to a beagle when age-adjusted) offers practical advantages for research
